[MO41] Mini-Oral Session 41　Gastrointestinal Cancer 3（Colorectal Cancer 1）
【E】

[MO41-5] PD-L1 promoter methylation predicts survival in advanced colorectal cancer patients who received preoperative CCRT

^○Kevin Chih-Yang Huang^1,8, Kun-San Clifford Chao^2,6, Shu-Fen Chiang³, Tao-Wei Ke⁴, William Tzu-Liang Chen⁵, Pei-Chen Yang⁶, Tsung-Wei Chen⁷ (1.Department of Biomedical image and Radiological Science, China Medical University, 2.Department of Radiotherapy, School of Medicine, China Medical University, 3.Lab of Precision Medicine, Feng-Yuan Hospital, 4.Department of Colorectal Surgery, China Medical University Hospital, China Medical University, 5.Department of Colorectal Surgery, China Medical University HsinChu Hospital, China Medical University, 6.Proton Therapy and Science Center, China Medical University Hospital, China Medical University, 7.Department of Pathology, Asia University Hospital, Asia University, 8.Translation Research Core, China Medical University Hospital)